EcoDrugPlus

Retinoid X Receptor Alpha

Ensembl ID : ENSUPAG00010008551
Gene Symbol: RXRA
1 Cross references
244 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSUPAG00010013376
Gene Symbol: RXRB
3 Cross references
234 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSUPAG00010023008
Gene Symbol: RXRG
1 Cross references
274 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSUPAG00010015209
Gene Symbol: RPL10A
3 Cross references
199 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSUPAG00010020974
Gene Symbol: RPL11
1 Cross references
160 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSUPAG00010016011
Gene Symbol: RPL13
3 Cross references
269 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSUPAG00010011004
Gene Symbol: RPL14
3 Cross references
257 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSUPAG00010019065
Gene Symbol: RPL18A
1 Cross references
164 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSUPAG00010007424
Gene Symbol: RPL19
1 Cross references
312 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSUPAG00010020498
Gene Symbol: RPL24
1 Cross references
218 Possible Orthologues:

Ribosomal Protein L26

Ensembl ID : ENSUPAG00010016587
Gene Symbol: RPL26
1 Cross references
196 Possible Orthologues:

Ribosomal Protein L27a

Ensembl ID : ENSUPAG00010023257
Gene Symbol: RPL27A
1 Cross references
229 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).